{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:18:56Z","timestamp":1790572736968,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.mito.2024.102000","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T12:17:43Z","timestamp":1733746663000},"page":"102000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Mitochondria-targeted nanotherapeutics: A new frontier in neurodegenerative disease treatment"],"prefix":"10.1016","volume":"81","author":[{"given":"Nishad","family":"Keethedeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Anantha Shenoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2024.102000_b0575","doi-asserted-by":"crossref","unstructured":"Abdellatif, A. A. H., Younis, M. A., Alsharidah, M., Al Rugaie, O. & Tawfeek, H. M. (2022). Biomedical applications of quantum dots: overview, challenges, and clinical potential. Int. J. Nanomedicine 17, 1951\u20131970.","DOI":"10.2147\/IJN.S357980"},{"key":"10.1016\/j.mito.2024.102000_b0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0010","doi-asserted-by":"crossref","unstructured":"Ames, B. N., Atamna, H. & Killilea, D. W. Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging. Molecular Aspects of Medicine vol. 26 363\u2013378 Preprint at Doi: 10.1016\/j.mam.2005.07.007 (2005).","DOI":"10.1016\/j.mam.2005.07.007"},{"key":"10.1016\/j.mito.2024.102000_b0015","doi-asserted-by":"crossref","first-page":"48410","DOI":"10.1074\/jbc.M108362200","article-title":"Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: Relevance to aging","volume":"276","author":"Atamna","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1356703","article-title":"Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson\u2019s disease","volume":"18","author":"Ay","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.mito.2024.102000_b0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial Dysfunction in Neurodegenerative Disorders","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2024.102000_b0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejmech.2019.01.055","article-title":"Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction","volume":"167","author":"Benfeito","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0045","doi-asserted-by":"crossref","first-page":"14304","DOI":"10.1523\/JNEUROSCI.0930-14.2014","article-title":"Loss of Mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons","volume":"34","author":"Berthet","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0055","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: opportunities for drug development","volume":"20","author":"Bhatia","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.mito.2024.102000_b0060","doi-asserted-by":"crossref","unstructured":"Bhushan, I. et al. (2018). Alzheimer\u2019s Disease: Causes & Treatment-A Review 1 MedDocs Publishers Annals of Biotechnology.","DOI":"10.33582\/2637-4927\/1002"},{"key":"10.1016\/j.mito.2024.102000_b0065","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1021\/acs.molpharmaceut.5b00320","article-title":"Effect of the conjugation density of triphenylphosphonium cation on the mitochondrial targeting of poly(amidoamine) dendrimers","volume":"12","author":"Bielski","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mito.2024.102000_b0070","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1016\/j.biomaterials.2012.03.032","article-title":"Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria","volume":"33","author":"Biswas","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.mito.2024.102000_b0075","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1038\/s41598-017-03411-7","article-title":"Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimer\u2019s disease","volume":"7","author":"Boonruamkaew","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mito.2024.102000_b0080","doi-asserted-by":"crossref","unstructured":"Boonruamkaew, P. et al. Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimer\u2019s disease. Sci. Rep. 7, 3785 (2017).","DOI":"10.1038\/s41598-017-03411-7"},{"key":"10.1016\/j.mito.2024.102000_b0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2024.102000_b0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1049\/nbt2.12018","article-title":"Types, properties and applications in drug delivery","volume":"15","author":"Bose","year":"2021","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.mito.2024.102000_b0095","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.nano.2016.10.004","article-title":"Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy","volume":"13","author":"Brenza","year":"2017","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0100","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2024.102000_b0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/abbi.1995.1436","article-title":"Synthesis and characterization of thiobutyltriphenylphosphonium bromide, a novel thiol reagent targeted to the mitochondrial matrix","volume":"322","author":"Burns","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mito.2024.102000_b0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","article-title":"Mitochondrial Dysfunction in Huntington\u2019s Disease","volume":"1049","author":"Carmo","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mito.2024.102000_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mam.2004.02.014","article-title":"Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease","volume":"25","author":"Carreras","year":"2004","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.mito.2024.102000_b0120","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bbrc.2016.07.055","article-title":"Pathways to mitochondrial dysfunction in ALS pathogenesis","volume":"483","author":"Carr\u00ec","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mito.2024.102000_b0125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-4159.2006.03777.x","article-title":"Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline","volume":"97","author":"Casarejos","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2024.102000_b0130","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1523\/JNEUROSCI.5308-07.2008","article-title":"Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants","volume":"28","author":"Cassina","year":"2008","journal-title":"J. Neurosci. off. J. Soc. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchemneu.2017.12.004","article-title":"Reinforcing mitochondrial functions in aging brain: An insight into Parkinson\u2019s disease therapeutics","volume":"95","author":"Chandra","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.mito.2024.102000_b0140","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1038\/cddis.2014.278","article-title":"Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin","volume":"5","author":"Charan","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mito.2024.102000_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212876","article-title":"A novel nanoparticle system targeting damaged mitochondria for the treatment of Parkinson\u2019s disease","volume":"138","author":"Chen","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.mito.2024.102000_b0150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","article-title":"Calcium signaling","volume":"131","author":"Clapham","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.mito.2024.102000_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.mito.2024.102000_b0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in ALS","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mito.2024.102000_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mito.2024.102000_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102037","article-title":"A mitochondria-targeted Caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson\u2019s disease patients","volume":"45","author":"Deus","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.mito.2024.102000_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuron.2014.11.027","article-title":"Parkinson\u2019s disease genes VPS35 and EIF4G1 interact genetically and converge on \u03b1-synuclein","volume":"85","author":"Dhungel","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2024.102000_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105783","article-title":"Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer\u2019s disease","volume":"171","author":"Ding","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mito.2024.102000_b0185","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/cdd.2014.72","article-title":"Cerium oxide nanoparticles protect against A\u03b2-induced mitochondrial fragmentation and neuronal cell death","volume":"21","author":"Dowding","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mito.2024.102000_b0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2014.09.042","article-title":"A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse model of Parkinson\u2019s disease","volume":"583","author":"Dranka","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mito.2024.102000_b0195","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2009.07.005","article-title":"Mitochondrial permeability transition pore in Alzheimer\u2019s disease: cyclophilin D and amyloid beta","volume":"1802","author":"Du","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2024.102000_b0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.mam.2004.03.001","article-title":"Mitochondria in health and disease: perspectives on a new mitochondrial biology","volume":"25","author":"Duchen","year":"2004","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.mito.2024.102000_b0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","article-title":"Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies","volume":"218","author":"Elfawy","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.mito.2024.102000_b0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.24.005.2009","article-title":"Microtubule depolymerization potentiates alpha-synuclein oligomerization","volume":"1","author":"Esteves","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.mito.2024.102000_b0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","article-title":"Mitochondria, oxidative stress and neurodegeneration","volume":"322","author":"Federico","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","article-title":"Bioenergetic dysfunction in Huntington\u2019s disease human cybrids","volume":"231","author":"Ferreira","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mito.2024.102000_b0235","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1097\/01.CCM.0000279192.96303.E7","article-title":"Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants","volume":"35","author":"Fink","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.mito.2024.102000_b0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2003.tb07469.x","article-title":"Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson\u2019s disease","volume":"991","author":"Fiskum","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.actbio.2020.03.029","article-title":"Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u2019s disease mice","volume":"108","author":"Gao","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mito.2024.102000_b0250","doi-asserted-by":"crossref","unstructured":"Gao, C. et al. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u2019s disease mice. Acta Biomater. 108, 285\u2013299 (2020).","DOI":"10.1016\/j.actbio.2020.03.029"},{"key":"10.1016\/j.mito.2024.102000_b0255","doi-asserted-by":"crossref","first-page":"58","DOI":"10.15252\/emmm.201505496","article-title":"CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis","volume":"8","author":"Genin","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0260","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.freeradbiomed.2010.08.028","article-title":"Neuroprotection by a mitochondria-targeted drug in a Parkinson\u2019s disease model","volume":"49","author":"Ghosh","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11481-016-9650-4","article-title":"Mitoapocynin treatment protects against neuroinflammation and dopaminergic neurodegeneration in a preclinical animal model of Parkinson\u2019s Disease","volume":"11","author":"Ghosh","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.mito.2024.102000_b0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2005.01.006","article-title":"Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington\u2019s Disease","volume":"52","author":"Goffredo","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mito.2024.102000_b0275","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/15548627.2016.1170257","article-title":"Defective recognition of LC3B by mutant SQSTM1\/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD","volume":"12","author":"Goode","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.mito.2024.102000_b0280","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/10717544.2020.1745328","article-title":"Neuronal mitochondria-targeted therapy for Alzheimer\u2019s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems","volume":"27","author":"Han","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mito.2024.102000_b0285","first-page":"529","article-title":"Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mito.2024.102000_b0290","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M111.307587","article-title":"In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production","volume":"286","author":"Hands","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0295","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci. off. J. Soc. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0300","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chembiol.2008.03.015","article-title":"Mitochondria-penetrating peptides","volume":"15","author":"Horton","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.mito.2024.102000_b0305","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1348-0421.2004.tb03621.x","article-title":"Quantum dots targeted to the assigned organelle in living cells","volume":"48","author":"Hoshino","year":"2004","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.mito.2024.102000_b0310","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2016.07.071","article-title":"Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons","volume":"478","author":"Hu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mito.2024.102000_b0315","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuron.2010.07.019","article-title":"Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS","volume":"67","author":"Israelson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2024.102000_b0320","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2015.02.034","article-title":"Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1","volume":"86","author":"Israelson","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2024.102000_b0325","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02254975","article-title":"How mitochondrial damage affects cell function","volume":"9","author":"James","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0330","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/acs.accounts.6b00277","article-title":"Peptide-mediated delivery of chemical probes and therapeutics to mitochondria","volume":"49","author":"Jean","year":"2016","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mito.2024.102000_b0335","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2023.02.076","article-title":"The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating \u03b2-amyloid plaque formation and mitochondrial\/synaptic deterioration in APP\/PS1 mice","volume":"658","author":"Jia","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mito.2024.102000_b0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10863-010-9286-7","article-title":"The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease","volume":"42","author":"Jin","year":"2010","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.mito.2024.102000_b0345","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2024.102000_b0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s12276-018-0124-z","article-title":"Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson\u2019s disease models","volume":"50","author":"Kang","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0355","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-122428","article-title":"Mitochondria-targeted plastoquinone antioxidant SkQ1 prevents amyloid-\u03b2-induced impairment of long-term potentiation in rat hippocampal slices","volume":"36","author":"Kapay","year":"2013","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.mito.2024.102000_b0360","doi-asserted-by":"crossref","first-page":"939","DOI":"10.15252\/embr.201540352","article-title":"Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation","volume":"16","author":"Kazlauskaite","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.mito.2024.102000_b0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuron.2013.02.029","article-title":"VCP Is essential for mitochondrial quality control by PINK1\/Parkin and this function Is impaired by VCP mutations","volume":"78","author":"Kim","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2024.102000_b0370","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1046\/j.1471-4159.2003.02263.x","article-title":"Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity: mitochondrial dysfunction and models of neurodegeneration","volume":"88","author":"Klivenyi","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2024.102000_b0375","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13073-016-0380-2","article-title":"Mitochondrial replacement approaches: challenges for clinical implementation","volume":"8","author":"Klopstock","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.mito.2024.102000_b0380","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2174\/1567205014666170621111033","article-title":"Antioxidant SkQ1 alleviates signs of Alzheimer\u2019s Disease-like pathology in Old OXYS rats by reversing mitochondrial deterioration","volume":"14","author":"Kolosova","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.mito.2024.102000_b0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1179\/174313208X331572","article-title":"Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington\u2019s disease knock-in striatal cell line","volume":"31","author":"Kong","year":"2009","journal-title":"Neurol. Res."},{"key":"10.1016\/j.mito.2024.102000_b0390","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1778","article-title":"Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons","volume":"38","author":"Kraytsberg","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0395","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","article-title":"Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.mito.2024.102000_b0400","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1002\/anie.201805052","article-title":"Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson\u2019s disease","volume":"57","author":"Kwon","year":"2018","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.mito.2024.102000_b0405","doi-asserted-by":"crossref","unstructured":"Kwon, H. J. et al. Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer\u2019s Disease. ACS Nano 10, 2860\u20132870 (2016).","DOI":"10.1021\/acsnano.5b08045"},{"key":"10.1016\/j.mito.2024.102000_b0410","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1089\/ars.2016.6905","article-title":"Mito-apocynin prevents mitochondrial dysfunction, microglial activation, oxidative damage, and progressive neurodegeneration in mitopark transgenic mice","volume":"27","author":"Langley","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mito.2024.102000_b0415","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1515\/BC.1999.080","article-title":"Dequalinium vesicles form stable complexes with plasmid DNA which are protected from DNase attack","volume":"380","author":"Lasch","year":"1999","journal-title":"Biol. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0420","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1073\/pnas.76.2.650","article-title":"Use of a lipophilic cation for determination of membrane potential in neuroblastoma-glioma hybrid cell suspensions","volume":"76","author":"Lichtshtein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2024.102000_b0425","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/15672026113109990060","article-title":"Mitochondrial fusion and fission proteins expression dynamically change in a murine model of amyotrophic lateral sclerosis","volume":"10","author":"Liu","year":"2013","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.mito.2024.102000_b0430","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.1021\/acsnano.3c09286","article-title":"In Situ self-assembled phytopolyphenol-coordinated intelligent nanotherapeutics for multipronged management of Ferroptosis-driven Alzheimer\u2019s disease","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mito.2024.102000_b0435","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2017.08.044","article-title":"Mitochondrial calcium imbalance in Parkinson\u2019s disease","volume":"663","author":"Ludtmann","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mito.2024.102000_b0440","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer\u2019s disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.mito.2024.102000_b0445","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1021\/acsami.7b18437","article-title":"Overcoming multidrug resistance through the GLUT1-mediated and enzyme-triggered mitochondrial targeting conjugate with redox-sensitive paclitaxel release","volume":"10","author":"Ma","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mito.2024.102000_b0450","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2024.102000_b0455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2015.08.004","article-title":"Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis","volume":"90","author":"Manfredi","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mito.2024.102000_b0460","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.2174\/0929867311320280007","article-title":"Nanocarriers for tracking and treating diseases","volume":"20","author":"Marrache","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0465","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.1073\/pnas.1210096109","article-title":"Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics","volume":"109","author":"Marrache","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2024.102000_b0470","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature08971","article-title":"Mutations of optineurin in amyotrophic lateral sclerosis","volume":"465","author":"Maruyama","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mito.2024.102000_b0475","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","article-title":"The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"31","author":"McManus","year":"2011","journal-title":"J. Neurosci. off. J. Soc. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0480","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","article-title":"Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences","volume":"281","author":"Milakovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0485","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2014.02.019","article-title":"Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis","volume":"70","author":"Miquel","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0490","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","article-title":"Early alterations of brain cellular energy homeostasis in Huntington disease models","volume":"287","author":"Mochel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0495","doi-asserted-by":"crossref","first-page":"E3349","DOI":"10.1073\/pnas.1523810113","article-title":"Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy","volume":"113","author":"Moore","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0500","first-page":"155","article-title":"GRP78 induction by calcium lonophore potentiates photodynamic therapy using the mitochondrial targeting dye Victoria blue BO","volume":"67","author":"Morgan","year":"1998","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.mito.2024.102000_b0505","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1063\/1.107019","article-title":"Atomic resolved material displacement on graphite surfaces by scanning tunnelling microscopy","volume":"60","author":"Moriarty","year":"1992","journal-title":"Appl. Phys. Lett."},{"key":"10.1016\/j.mito.2024.102000_b0510","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/14712598.1.5.753","article-title":"Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction","volume":"1","author":"Murphy","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.mito.2024.102000_b0515","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mito.2024.102000_b0520","first-page":"99","article-title":"Deferoxamine and curcumin loaded nanocarriers protect against rotenone-induced neurotoxicity","volume":"10","author":"Mursaleen","year":"2020","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.mito.2024.102000_b0525","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/antiox9070600","article-title":"N-acetylcysteine nanocarriers protect against oxidative stress in a cellular model of Parkinson\u2019s disease","volume":"9","author":"Mursaleen","year":"2020","journal-title":"Antioxid. Basel Switz."},{"key":"10.1016\/j.mito.2024.102000_b0530","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/antiox12010130","article-title":"Curcumin and N-acetylcysteine nanocarriers alone or combined with deferoxamine target the mitochondria and protect against neurotoxicity and oxidative stress in a co-culture model of Parkinson\u2019s disease","volume":"12","author":"Mursaleen","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.mito.2024.102000_b0535","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-4-35","article-title":"Apolipoprotein E4 (1\u2013272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells","volume":"4","author":"Nakamura","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mito.2024.102000_b0540","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/NEN.0000000000000197","article-title":"Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model","volume":"74","author":"Naseri","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mito.2024.102000_b0545","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.freeradbiomed.2014.03.003","article-title":"The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease","volume":"71","author":"Ng","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0550","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","article-title":"A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis","volume":"75","author":"Nishimura","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.mito.2024.102000_b0560","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-016-0316-5","article-title":"Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts","volume":"4","author":"Onesto","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.mito.2024.102000_b0565","doi-asserted-by":"crossref","unstructured":"Perez Ortiz, J. M. & Swerdlow, R. H. Mitochondrial dysfunction in Alzheimer\u2019s disease: Role in pathogenesis and novel therapeutic opportunities. Br. J. Pharmacol. 176, 3489\u20133507 (2019).","DOI":"10.1111\/bph.14585"},{"key":"10.1016\/j.mito.2024.102000_b0570","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1073\/pnas.83.24.9729","article-title":"Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells","volume":"83","author":"Oseroff","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mito.2024.102000_b0580","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jchemed.0c01403","article-title":"Categorization of quantum dots, clusters, nanoclusters, and nanodots","author":"Park","year":"2021","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.mito.2024.102000_b0585","doi-asserted-by":"crossref","unstructured":"Paul, W. & Sharma, C. P. Inorganic nanoparticles for targeted drug delivery. in Biointegration of Medical Implant Materials (Second Edition) (ed. Sharma, C. P.) 333\u2013373 (Woodhead Publishing, 2020). doi:10.1016\/B978-0-08-102680-9.00013-5.","DOI":"10.1016\/B978-0-08-102680-9.00013-5"},{"key":"10.1016\/j.mito.2024.102000_b0590","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.22034","article-title":"Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins","volume":"68","author":"Perier","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2024.102000_b0595","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-4159.2006.04018.x","article-title":"Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis","volume":"98","author":"Petri","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2024.102000_b0600","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/molecules26030543","article-title":"pH-responsive redox nanoparticles protect SH-SY5Y cells at lowered pH in a cellular model of Parkinson\u2019s disease","volume":"26","author":"Pichla","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.mito.2024.102000_b0605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-016-0313-8","article-title":"ALS-linked misfolded SOD1 species have divergent impacts on mitochondria","volume":"4","author":"Pickles","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.mito.2024.102000_b0610","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, Parkin and Mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2024.102000_b0615","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yexmp.2006.09.008","article-title":"Mitochondrial dysfunction and molecular pathways of disease","volume":"83","author":"Pieczenik","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.mito.2024.102000_b0620","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2019.11.021","article-title":"The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington\u2019s disease mice","volume":"146","author":"Pinho","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0625","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/hmg\/ddw051","article-title":"Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes","volume":"25","author":"Polyzos","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0630","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.2c05795","article-title":"Cholinergic neuron targeting nanosystem delivering hybrid peptide for combinatorial mitochondrial therapy in Alzheimer\u2019s disease","author":"Qian","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.mito.2024.102000_b0635","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/cdd.2012.95","article-title":"Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency","volume":"20","author":"Ramonet","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mito.2024.102000_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119752","article-title":"Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1\/M2 microglial polarization in an Alzheimer\u2019s disease model","volume":"232","author":"Ren","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.mito.2024.102000_b0645","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","article-title":"Insulin and IGF-1 improve mitochondrial function in a PI-3K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington\u2019s disease knock-in striatal cells","volume":"74","author":"Ribeiro","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2024.102000_b0650","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.mito.2024.102000_b0655","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer\u2019s disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.mito.2024.102000_b0660","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.parkreldis.2008.08.003","article-title":"Genetic variation of Omi\/HtrA2 and Parkinson\u2019s disease","volume":"14","author":"Ross","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mito.2024.102000_b0665","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0b013e31826e25df","article-title":"SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"79","author":"Rubino","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2024.102000_b0670","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/ijms23031134","article-title":"Changes in glial support of the hippocampus during the development of an Alzheimer\u2019s disease-like pathology and their correction by mitochondria-targeted antioxidant SkQ1","volume":"23","author":"Rudnitskaya","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0675","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"Rui","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mito.2024.102000_b0680","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tins.2014.03.004","article-title":"Parkin and PINK1: much more than mitophagy","volume":"37","author":"Scarffe","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0685","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1007\/s11064-008-9855-x","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"33","author":"Schapira","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.mito.2024.102000_b0690","doi-asserted-by":"crossref","unstructured":"Schenkel, L. C. & Bakovic, M. (2014). Formation and Regulation of Mitochondrial Membranes. Int. J. Cell Biol. vol. 2014 e709828 https:\/\/www.hindawi.com\/journals\/ijcb\/2014\/709828\/.","DOI":"10.1155\/2014\/709828"},{"key":"10.1016\/j.mito.2024.102000_b0695","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.7150\/thno.29039","article-title":"Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics","volume":"8","author":"Sharma","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.mito.2024.102000_b0700","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1021\/acs.biomac.0c01033","article-title":"Targeting mitochondria in tumor-associated macrophages using a dendrimer-conjugated TSPO ligand that stimulates antitumor signaling in glioblastoma","volume":"21","author":"Sharma","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mito.2024.102000_b0705","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0710","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0715","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.brainresrev.2007.04.007","article-title":"Mitochondrial mechanisms of estrogen neuroprotection","volume":"57","author":"Simpkins","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.mito.2024.102000_b0720","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-2010-1239","article-title":"Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment","volume":"19","author":"Smith","year":"2010","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.mito.2024.102000_b0725","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of bioactive molecules to mitochondria in vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2024.102000_b0730","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord. off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.mito.2024.102000_b0735","first-page":"174","article-title":"The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson\u2019s disease","author":"Solesio","year":"1832","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.mito.2024.102000_b0740","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.mito.2024.102000_b0745","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-131034","article-title":"Alzheimer\u2019s disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1","volume":"38","author":"Stefanova","year":"2014","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.mito.2024.102000_b0750","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3984906","article-title":"Suppression of Alzheimer\u2019s disease-Like pathology progression by mitochondria-targeted antioxidant SkQ1: A transcriptome profiling study","volume":"2019","author":"Stefanova","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.mito.2024.102000_b0755","first-page":"2028","article-title":"Evaluation of amino-functional polyester dendrimers Based on Bis-MPA as nonviral vectors for siRNA delivery","volume":"23","author":"Stenstr\u00f6m","year":"2018","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.mito.2024.102000_b0760","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1038\/ncomms4996","article-title":"ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS\/FTD-associated TDP-43","volume":"5","author":"Stoica","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mito.2024.102000_b0765","doi-asserted-by":"crossref","first-page":"E521","DOI":"10.1208\/aapsj080362","article-title":"Mitochondria-targeted peptide antioxidants: novel neuroprotective agents","volume":"8","author":"Szeto","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.mito.2024.102000_b0770","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1196\/annals.1427.013","article-title":"Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases","volume":"1147","author":"Szeto","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0775","article-title":"Mitochondria-targeted nanoparticles (mitoNANO): an emerging therapeutic shortcut for cancer","volume":"3","author":"Tabish","year":"2021","journal-title":"Biomater. Biosyst."},{"key":"10.1016\/j.mito.2024.102000_b0780","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.mito.2011.08.004","article-title":"A novel mitotropic oligolysine nanocarrier: targeted delivery of covalently bound D-Luciferin to cell mitochondria","volume":"11","author":"Theodossiou","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2024.102000_b0785","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1007\/s11095-013-1111-7","article-title":"Mitochondrial delivery of doxorubicin by triphenylphosphonium-functionalized hyperbranched nanocarriers results in rapid and severe cytotoxicity","volume":"30","author":"Theodossiou","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mito.2024.102000_b0790","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.3390\/ijms241310494","article-title":"Mitochondria-Targeted delivery strategy of dual-loaded liposomes for Alzheimer\u2019s disease therapy","volume":"24","author":"Vasileva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0795","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1083\/jcb.107.6.2045","article-title":"Mitochondria can import artificial precursor proteins containing a branched polypeptide chain or a carboxy-terminal stilbene disulfonate","volume":"107","author":"Vestweber","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mito.2024.102000_b0800","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nbt1006-1211","article-title":"The emerging nanomedicine landscape","volume":"24","author":"Wagner","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mito.2024.102000_b0805","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.1305-11.2012","article-title":"Transgenic mouse model expressing the caspase 6 fragment of mutant Huntingtin","volume":"32","author":"Waldron-Roby","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0810","doi-asserted-by":"crossref","unstructured":"Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. vol. 39 359\u2013407 Preprint at Doi: 10.1146\/annurev.genet.39.110304.095751 (2005).","DOI":"10.1146\/annurev.genet.39.110304.095751"},{"key":"10.1016\/j.mito.2024.102000_b0815","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-\u03b2 overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mito.2024.102000_b0820","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"Wang","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0825","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","article-title":"The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons","volume":"22","author":"Wang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2021.109151","article-title":"Treatment of Parkinson\u2019s disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments","volume":"249","author":"Wang","year":"2021","journal-title":"Comp. Biochem. Physiol. Toxicol. Pharmacol. CBP"},{"key":"10.1016\/j.mito.2024.102000_b0835","first-page":"498","article-title":"Nanopreparations for mitochondria targeting drug delivery system: current strategies and future prospective","volume":"12","author":"Wang","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0840","first-page":"1665","article-title":"Therapeutic benefits of H2S in Alzheimer\u2019s disease","volume":"21","author":"Wei","year":"2014","journal-title":"J. Clin. Neurosci. off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.mito.2024.102000_b0845","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1023\/A:1011991307631","article-title":"DQAsomes: a novel potential drug and gene delivery system made from Dequalinium","volume":"15","author":"Weissig","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mito.2024.102000_b0850","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/17425247.2.1.89","article-title":"Targeted drug delivery to mammalian mitochondria in living cells","volume":"2","author":"Weissig","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.mito.2024.102000_b0855","doi-asserted-by":"crossref","unstructured":"Weissig, V., Boddapati, S. V. & Cheng, G. G. M. D. and S. M. (2003). Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria. Drug Design Reviews - Online (Discontinued) vol. 1 15\u201328 https:\/\/www.eurekaselect.com\/91056\/article.","DOI":"10.2174\/1567269043480735"},{"key":"10.1016\/j.mito.2024.102000_b0860","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-409X(01)00131-4","article-title":"Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems","volume":"49","author":"Weissig","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mito.2024.102000_b0865","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.bbadis.2018.05.018","article-title":"MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1\u03b1","volume":"1864","author":"Xi","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.mito.2024.102000_b0870","doi-asserted-by":"crossref","first-page":"17979","DOI":"10.1021\/acsnano.3c04308","article-title":"Facilitating pro-survival mitophagy for alleviating parkinson\u2019s disease via sequence-targeted lycopene nanodots","volume":"17","author":"Xia","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mito.2024.102000_b0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120339","article-title":"Brain-targeted delivery shuttled by black phosphorus nanostructure to treat Parkinson\u2019s disease","volume":"260","author":"Xiong","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.mito.2024.102000_b0880","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.celrep.2012.10.001","article-title":"Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington\u2019s disease","volume":"2","author":"Xun","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.mito.2024.102000_b0885","doi-asserted-by":"crossref","unstructured":"Xun, Z. et al. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington\u2019s disease. Cell Rep. 2, 1137\u20131142 (2012).","DOI":"10.1016\/j.celrep.2012.10.001"},{"key":"10.1016\/j.mito.2024.102000_b0890","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2009.2445","article-title":"Mitochondria targeted peptides protect against 1-methyl-4-Phenyl-1,2,3,6-tetrahydropyridine neurotoxicity","volume":"11","author":"Yang","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mito.2024.102000_b0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119844","article-title":"Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer\u2019s disease","volume":"238","author":"Yang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.mito.2024.102000_b0900","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington\u2019s disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2024.102000_b0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103409","article-title":"The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice","volume":"101","author":"Young","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.mito.2024.102000_b0910","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1471-4159.2003.02260.x","article-title":"Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington\u2019s disease","volume":"87","author":"Zhang","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2024.102000_b0915","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8360738","article-title":"AP39, a mitochondria-targeted hydrogen sulfide donor, supports cellular bioenergetics and protects against Alzheimer\u2019s disease by preserving mitochondrial function in APP\/PS1 mice and neurons","volume":"2016","author":"Zhao","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.mito.2024.102000_b0920","first-page":"578","article-title":"Nanomotor-based H2S donor with mitochondrial targeting function for treatment of Parkinson\u2019s disease","volume":"31","author":"Zhao","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mito.2024.102000_b0925","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bcp.2005.08.022","article-title":"Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines","volume":"70","author":"Zhao","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mito.2024.102000_b0930","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300758","article-title":"Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson\u2019s disease","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mito.2024.102000_b0935","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200748","article-title":"Design and synthesis of a mitochondrial-targeted JNK inhibitor and its protective effect on Parkinson\u2019s disease phenotypes","volume":"24","author":"Zhou","year":"2023","journal-title":"ChemBioChem"},{"key":"10.1016\/j.mito.2024.102000_b0940","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles: production, characterization, Toxicology and Ecotoxicology","volume":"25","author":"Zieli\u0144ska","year":"2020","journal-title":"Molecules"}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724924001582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724924001582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:52:13Z","timestamp":1762552333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724924001582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":187,"alternative-id":["S1567724924001582"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2024.102000","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria-targeted nanotherapeutics: A new frontier in neurodegenerative disease treatment","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2024.102000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. and Mitochondria Research Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102000"}}